Clinical and morphological features in patients with advanced endometrial cancer treated with immunotargeting therapy

Clinical and morphological features in patients with advanced endometrial cancer treated with immunotargeting therapy

Background. Endometrial cancer (EC) is one of the most significant oncogynecological problems. The main mortality cause in this disease, as in the case of other malignant neoplasms, is the tumor progression. The presence of mutations associated with mismatch repair-deficient is of great prognostic i...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Kolomiets, M. N. Stakheeva, O. N. Churuksaeva, A. B. Villert, A. L. Chernyshova, V. G. Sisakyan, I. Yu. Lots, N. M. Chernorubashkina, V. N. Zhurman, A. A. Grechkina, E. N. Aleksandrova, N. E. Musaeva, O. V. Diduk, N. A. Bulygina, D. A. Pyatina, I. L. Obraz, A. V. Krechetova, M. A. Danilova, M. A. Khodzhakhova, A. A. Malsteva, N. A. Ermak
Format: Article
Language:Russian
Published: ABV-press 2023-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
endometrial cancer
clinical and morphological features
progression-free survival
immunotargeting therapy
lenvatinib
pembrolizumab
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1095
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://ojrs.abvpress.ru/ojrs/article/view/1095

Similar Items